Singapore Institute, IBM Of U.S. Seek Collaborator For Key Nanodrug
This article was originally published in PharmAsia News
Executive Summary
Singapore scientists collaborated with U.S.-based IBM to develop a nanoparticle drug that could prove effective in combatting antibiotic-resistant bacteria